The therapy of kidney cancer with biomolecular drugsGiuseppe Di Lorenzo, Giacomo Cartenì, Carlo Buonerba et al.|Cancer Treatment Reviews|2010Cited by 35
Target therapy in metastatic renal cell carcinomaGiacomo Cartenì, N. Panza, Giovanni Esposito et al.|European Journal of Cancer Supplements|2008Cited by 2
A phase II study of octreotide in metastatic advanced prostatic cancer (MAPC)A. Tucci, G Pacilio, Giacomo Cartenì et al.|European Journal of Cancer and Clinical Oncology|1991Cited by 2
Phase II trial of paclitaxel (P) and cisplatin (COOP) in patients with advanced breast cancer refractory to anthracycline (A) therapyFerdinando Riccardi, G Pacilio, G. Rosati et al.|European Journal of Cancer|1997Cited by 1
Protracted infusion (PI) of 5-FU+FA in advanced colorectal cancerFerdinando Riccardi, G Pacilio, Giacomo Cartenì et al.|European Journal of Cancer and Clinical Oncology|1991Cited by 0